Date: May 09, 2012 Source: (
click here to go to the source)
nanoRETE, Inc. announced today that it has been awarded a Phase II contract under the Air Force Small Business Innovation Research (SBIR) program for the continued development of a "field-appropriate biosensor for the detection on Mycobacterium tuberculosis infection," a latently infectious form of TB. The award enables nanoRETE to build upon proprietary technology developed under the previously completed SBIR Phase I contract.
Development work will take place over a two year period, with an estimated funding level of $750,000. The company has also been awarded a matching grant for $125,000 under the State of Michigan's Emerging Technology Fund (ETF) to help support and expand the efforts under this program.
"We are pleased to have received the Air Force award, which serves as strong validation of our Phase I contract activities, as well as our overall work in the area of nano-particle based biosensors for pathogen and toxin detection," said Fred Beyerlein, nanoRETE CEO. "We are also very appreciative of the ETF grant, which will enable us to further expand our work and translate it into other potential commercial and employment opportunities. Via both funding and its many support programs, the State of Michigan has proven to be a strong partner in helping nanoRETE to form, develop, and grow."
About nanoRETE
nanoRETE, Inc. is a Lansing, Michigan-based company that is developing technologies to provide real-time detection of pathogens and toxins using customized, proprietary nanoparticle biosensors based on a core technology exclusively licensed from Michigan State University. The company is developing products that can test for single or multiple pathogens/ toxins using a simple-to-use device that can generate screening results in approximately 2-3 hours in a very cost effective manner. Applications of the technology are targeted towards detection and subsequent protection in the commercial food industry, healthcare industry, and future military applications.
